119 related articles for article (PubMed ID: 20222171)
1. T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis.
Cheng JF; Ning YJ; Zhang W; Lu ZH; Lin L
World J Gastroenterol; 2010 Mar; 16(10):1258-66. PubMed ID: 20222171
[TBL] [Abstract][Full Text] [Related]
2. ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta-analysis on inflammatory bowel disease risk and clinical outcomes.
Simovic I; Hilmi I; Ng RT; Chew KS; Wong SY; Lee WS; Riordan S; Castaño-Rodríguez N
United European Gastroenterol J; 2024 Feb; 12(1):103-121. PubMed ID: 37837511
[TBL] [Abstract][Full Text] [Related]
3. The
Chesney KL; Men H; Hankins MA; Bryda EC
Physiol Genomics; 2021 Jun; 53(6):269-281. PubMed ID: 33818130
[No Abstract] [Full Text] [Related]
4. Association of ATG10 rs1864183, ATG16L1 rs2241880 and miR-126 with esophageal cancer.
Bali JS; Sambyal V; Mehrotra S; Gupta P; Guleria K; Uppal MS; Sudan M
Mol Biol Rep; 2024 Jan; 51(1):231. PubMed ID: 38281293
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: analysis of the organization of the Atg16L1 complex in fibroblasts.
Fujita N; Saitoh T; Kageyama S; Akira S; Noda T; Yoshimori T
J Biol Chem; 2009 Nov; 284(47):32602-9. PubMed ID: 19783656
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
Blom K; Rubin J; Halfvarson J; Törkvist L; Rönnblom A; Sangfelt P; Lördal M; Jönsson UB; Sjöqvist U; Håkansson LD; Venge P; Carlson M
World J Gastroenterol; 2012 Nov; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms of IL23R and IL17 with ulcerative colitis risk in a Chinese Han population.
Yu P; Shen F; Zhang X; Cao R; Zhao X; Liu P; Tu H; Yang X; Shi R; Zhang H
PLoS One; 2012; 7(9):e44380. PubMed ID: 22984500
[TBL] [Abstract][Full Text] [Related]
8. Association study of 71 European Crohn's disease susceptibility loci in a Japanese population.
Hirano A; Yamazaki K; Umeno J; Ashikawa K; Aoki M; Matsumoto T; Nakamura S; Ninomiya T; Matsui T; Hirai F; Kawaguchi T; Takazoe M; Tanaka H; Motoya S; Kiyohara Y; Kitazono T; Nakamura Y; Kamatani N; Kubo M
Inflamm Bowel Dis; 2013 Mar; 19(3):526-33. PubMed ID: 23388546
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
Franke A; McGovern DP; Barrett JC; Wang K; Radford-Smith GL; Ahmad T; Lees CW; Balschun T; Lee J; Roberts R; Anderson CA; Bis JC; Bumpstead S; Ellinghaus D; Festen EM; Georges M; Green T; Haritunians T; Jostins L; Latiano A; Mathew CG; Montgomery GW; Prescott NJ; Raychaudhuri S; Rotter JI; Schumm P; Sharma Y; Simms LA; Taylor KD; Whiteman D; Wijmenga C; Baldassano RN; Barclay M; Bayless TM; Brand S; Büning C; Cohen A; Colombel JF; Cottone M; Stronati L; Denson T; De Vos M; D'Inca R; Dubinsky M; Edwards C; Florin T; Franchimont D; Gearry R; Glas J; Van Gossum A; Guthery SL; Halfvarson J; Verspaget HW; Hugot JP; Karban A; Laukens D; Lawrance I; Lemann M; Levine A; Libioulle C; Louis E; Mowat C; Newman W; Panés J; Phillips A; Proctor DD; Regueiro M; Russell R; Rutgeerts P; Sanderson J; Sans M; Seibold F; Steinhart AH; Stokkers PC; Torkvist L; Kullak-Ublick G; Wilson D; Walters T; Targan SR; Brant SR; Rioux JD; D'Amato M; Weersma RK; Kugathasan S; Griffiths AM; Mansfield JC; Vermeire S; Duerr RH; Silverberg MS; Satsangi J; Schreiber S; Cho JH; Annese V; Hakonarson H; Daly MJ; Parkes M
Nat Genet; 2010 Dec; 42(12):1118-25. PubMed ID: 21102463
[TBL] [Abstract][Full Text] [Related]
10. ATG16L1: A multifunctional susceptibility factor in Crohn disease.
Salem M; Ammitzboell M; Nys K; Seidelin JB; Nielsen OH
Autophagy; 2015 Apr; 11(4):585-94. PubMed ID: 25906181
[TBL] [Abstract][Full Text] [Related]
11. Beyond autophagy: LC3-associated phagocytosis and endocytosis.
Peña-Martinez C; Rickman AD; Heckmann BL
Sci Adv; 2022 Oct; 8(43):eabn1702. PubMed ID: 36288309
[TBL] [Abstract][Full Text] [Related]
12. UEG Week 2020 Oral Presentations.
United European Gastroenterol J; 2020 Oct; 8(8_suppl):8-142. PubMed ID: 33043828
[No Abstract] [Full Text] [Related]
13. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development-A Focus on Ulcerative Colitis.
Samoilă I; Dinescu S; Costache M
Cells; 2020 Jul; 9(7):. PubMed ID: 32659925
[TBL] [Abstract][Full Text] [Related]
14. Role of autophagy in the pathogenesis of inflammatory bowel disease.
Iida T; Onodera K; Nakase H
World J Gastroenterol; 2017 Mar; 23(11):1944-1953. PubMed ID: 28373760
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in autophagy genes are associated with paget disease of bone.
Usategui-Martín R; García-Aparicio J; Corral-Gudino L; Calero-Paniagua I; Del Pino-Montes J; González Sarmiento R
PLoS One; 2015; 10(6):e0128984. PubMed ID: 26030385
[TBL] [Abstract][Full Text] [Related]
16. A SPECIAL MEETING REVIEW EDITION: Highlights in Anti-Tumor Necrosis Factor Monitoring and Antibody Monitoring From the 2014 DDW Meeting: Digestive Disease Week 2014 May 3-6, 2014 • Chicago, Illinois: Special Reporting on:• Therapeutic Monitoring of Anti-TNF Levels and Antibodies to Predict Response and Achieve Mucosal Healing• Prospective Therapeutic Drug Monitoring and Optimization of Infliximab Maintenance Therapy in IBD• Classification of Non-IBD, Crohn's Disease and Ulcerative Colitis in a Young Patient Population Using a Multi-Marker Diagnostic Panel• Persistence of Antibodies to Infliximab for More Than Two Months Predicts Loss of Response to Infliximab in Inflammatory Bowel Diseases• Pre-Operative Serological Markers May Predict Postoperative Crohn's Disease Recurrence: Results From a Prospective Mono-Centric Trial• Antibodies and Levels of Biologies-Reactive vs Proactive Measurements• Higher 6-Thioguanine Nucleotide Concentrations Are Associated With Higher Trough Levels of Infliximab in Patients on Combination Therapy• The Clinical and Immunological Significance of Low Levels of Infliximab in the Absence of Anti-lnfliximab Antibodies in Patients With IBD• Antibodies to Adalimumab Predict Inflammation in Crohn's Patients on Maintenance Adalimumab Therapy• ATG16L1 Genotype Is Associated With Response to Anti-TNFWith Expert Commentary by:William J. Sandborn, MDProfessor and Chief, Division of Gastroenterology Director, UCSD IBD CenterUC San Diego Health SystemLa Jolla, California.
Gastroenterol Hepatol (N Y); 2014 Jul; 10(7 Suppl 4):1-20. PubMed ID: 25892982
[No Abstract] [Full Text] [Related]
17. Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.
Rigoli L; Caruso RA
World J Gastroenterol; 2014 Aug; 20(30):10262-78. PubMed ID: 25132743
[TBL] [Abstract][Full Text] [Related]
18. Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B).
Dalton JP; Desmond A; Shanahan F; Hill C
Med Microbiol Immunol; 2014 Jun; 203(3):195-205. PubMed ID: 24522266
[TBL] [Abstract][Full Text] [Related]
19. Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects.
Lu X; Tang L; Li K; Zheng J; Zhao P; Tao Y; Li LX
Sci Rep; 2014 Jan; 4():3924. PubMed ID: 24473197
[TBL] [Abstract][Full Text] [Related]
20. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
Plevy S; Silverberg MS; Lockton S; Stockfisch T; Croner L; Stachelski J; Brown M; Triggs C; Chuang E; Princen F; Singh S
Inflamm Bowel Dis; 2013 May; 19(6):1139-48. PubMed ID: 23518807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
